Finally, 14 weeks post Mrps5 ablation (7 weeks post AAV9 infection), only AAV9-Klf15 treatment continued to ameliorate the cardiac phenotype of Mrps5cKO mice (Fig. 4n–p and Supplementary Fig. 5n, o). This evidence concerns the gene MRPS5 and infection.